Effects of 1 alpha-hydroxyvitamin D3 on experimental uremic renal osteodystrophy in rats induced by Na-sulfacetylthiazole.
D000818:Animals; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000032:analysis / Q000097:blood; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D005269:Femur / Q000032:analysis / Q000473:pathology; D006887:Hydroxycholecalciferols / Q000097:blood / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D008297:Male; D010280:Parathyroid Glands / Q000473:pathology; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D051381:Rats; D013844:Thiazoles / Q000008:administration & dosage; D014511:Uremia / Q000139:chemically induced / Q000188:drug therapy*
D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D013844:Thiazoles; D010758:Phosphorus; D002118:Calcium